OHSU

Research Studies

The Western States Node has participated in 34 CTN protocols or ancillary studies in collaboration with Community Treatment Programs in Arizona, Colorado, Hawaii, Northern California, and Oregon as well as other CTN Nodes.

CTN Protocols

CTN-0049: Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

CTN-0048: Cocaine Use Reduction with Buprenorphine (CURB)

CTN-0046-A-1: Site Influences on Treatment Effects - Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependent Outcome

CTN-0046: Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence

CTN-0044-A-2: Acceptability of a Web-delivered, Evidence-based, Psychosocial Intervention among Individuals with Substance Use Disorders who Identify as American Indian/Alaska Native

CTN-0044: Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders

CTN-0043-S: Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations

CTN-0038-Ot: Barriers to Substance Abuse Treatment Among Asian Americans and Pacific Islanders

CTN-0035-Ot: Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment

CTN-0033-Ot-5: The Choctaw Nation Methamphetamine Data Needs Project

CTN-0033-Ot-1: Methamphetamine Use Among American Indians

CTN-0032-A-1: Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs

CTN-0031-A-3: Organizational and Practitioner Influences on Implementation of STAGE-12

CTN-0031-A-1: An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers

CTN-0031: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

CTN-0030-A-1: Collection of Economic Data for the Prescription Opioid Addiction Treatment Study

CTN-0030: Prescription Opiate Abuse Treatment Study (POATS)

CTN-0029: A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD

CTN-0027-A-2: Retention of Suboxone Patients in START: Perspectives of Providers and Patients

CTN-0027-A-1: START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies

CTN-0027: Starting Treatment with Agonist Replacement Therapies (START)

CTN-0021: Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

CTN-0020: Job Seekers Training for Patients with Drug Dependence

CTN-0018: Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

CTN-0017: HIV and HCV Intervention in Drug Treatment Settings

CTN-0014-A-1: Mediators and Moderators of Brief Strategic Family Therapy (BSFT) for Adolescent Drug Use

CTN-0014: Brief Strategic Family Therapy for Adolescent Drug Abusers

CTN-0012: Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

CTN-0008: Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

CTN-0005: MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

CTN-0003: Suboxone (Buprenorphine / Naloxone) Taper: A Comparison of Taper Schedules

CTN-0002: Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification